LRRC15 is primarily expressed in innate immune barriers including placenta, skin, and lymphatic tissues as well as perturbed-state tissue fibroblasts, and we found LRRC15 protein is absent in control lungs, but highly expressed in COVID-19 patients, where it lines the airways. Here, LRRC15 is linked to COVID-19.